Trial Profile
A Prospective Trial to Assess Analgesic Efficacy of Liposomal Bupivacaine vs. Bupivacaine HCL as a Tap Block After Abdominally Based Autologous Breast Reconstruction
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 21 Feb 2019
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary) ; Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 14 Aug 2018 Status changed from suspended to discontinued as interim analysis showed that there was no difference between the two drugs
- 02 May 2018 Status changed from recruiting to suspended due to interim analysis.
- 08 Feb 2017 Planned End Date changed from 1 May 2019 to 31 May 2019.